PE anti-human Ganglioside GD2 357303 from BioLegend

Product Specs
ItemPE anti-human Ganglioside GD2
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number357303
Quantity25 tests
ApplicationsFlow Cytometry (FC)
Conjugate/TagPE
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ReactivityHuman
IsotypeIgG2a, Kappa
Clone14G2a
Antibody TypePrimary
ImmunogenNeuroblastoma cell line LAN-1
NCBI Full Gene Namebeta-1,4-N-acetyl-galactosaminyltransferase 1
NCBI Gene AliasesGALGT, GALNACT, GalNAc-T, SPG26
ClonalityMonoclonal
TargetGanglioside GD2
HostMouse

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) settingPLOS ONEAugust 12, 2021Kara Magee et al.and the bottom section was incubated with 1:100 anti-GD2-PE (BioLegend clone 14.G2a, catalogue number 357304) in 1% FBS overnight at 4°C in a dark humidity chamber Slides were then washed in 1% FBS in PBS for

(2) Expression of Potential Targets for Cell-Based Therapies on Melanoma CellsLife (Basel, Switzerland)March 24, 2021Strobel SB, Machiraju D, Hülsmeyer I, Becker JC, Paschen A, Jäger D, Wels WS, Bachmann M, Hassel JC.cell panel: mouse monoclonal HER2 AF647(clone 24D2; #324412), mouse monoclonal GD2 PE (clone 14G2a; #357304), and corresponding Isotypes. After staining for surface markers, cells were washed twice with FACS

(3) Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2⁺ Murine NeuroblastomaFrontiers in immunologyJanuary 1, 2021Bates PD, Rakhmilevich AL, Cho MM, Bouchlaka MN, Rao SL, Hales JM, Orentas RJ, Fry TJ, Gilles SD, Sondel PM, et al.CD45.1-APC (Cat # 110714, BioLegend) or CD45.1-Pacific Blue (Cat # 110722, BioLegend), GD2 PE (Cat# 357304, BioLegend), FasL-APC (Cat # 106610, BioLegend), and TRAIL-PerCP-Cy5.5 (Cat # 109314, BioLegend) and

(4) Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma modelJournal for immunotherapy of cancerOctober 1, 2020Baniel CC, Sumiec EG, Hank JA, Bates AM, Erbe AK, Pieper AA, Hoefges AG, Patel RB, Rakhmilevich AL, Morris ZS, et al.one controls were used. Binding inhibition flow cytometry Mouse anti-GD2 mAb 14G2a-PE (Biolegend #357304) was added to either MAHA+ or naive mouse serum (1–10 μL) to a total volume of 50 µL of 2% FBS flow cytometry

(5) In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral ResponseFrontiers in immunologyJanuary 1, 2020Baniel CC, Heinze CM, Hoefges A, Sumiec EG, Hank JA, Carlson PM, Jin WJ, Patel RB, Sriramaneni RN, Gillies SD, et al.After transduction, B16-GD2+ and Panc02-GD2+ cells were labeled using PE-conjugated anti-GD2 (14G2a-PE, 357304, BioLegend) and sorted on a BD FACSAria flow cytometer to isolate GD2+ cells with the highest GD2 expression.

(6) Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibitionJournal for immunotherapy of cancerDecember 6, 2019Voeller J, Erbe AK, Slowinski J, Rasmussen K, Carlson PM, Hoefges A, VandenHeuvel S, Stuckwisch A, Wang X, Gillies SD, et al.

(7) Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samplesF1000ResearchJanuary 1, 2019Barton J, Pacey K, Jain N, Kasia T, Edwards D, Thevanesan C, Straathof K, Barone G, Anderson J.using the following panel of directly conjugated monoclonal antibodies all from Biolegend: GD2-PE (357304, RRID: AB_2561885), CD56-APC/Cy7 (318332, RRID: AB_10896424), CD45-BV711 (304049, RRID: AB_2563465)

(8) Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor SitesCancer immunology researchJuly 1, 2018Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael LL, et al.London) (34). After transduction, Panc02-GD2+ cells were labeled using PE-conjugated anti-GD2 (14G2a-PE, 357304, Biolegend) and sorted on a BD FACsAria flow cytometer to isolate Panc02-GD2+ cells with the highest

(9) High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelCancer immunology researchJanuary 1, 2018Richman SA, Nunez-Cruz S, Moghimi B, Li LZ, Gershenson ZT, Mourelatos Z, Barrett DM, Grupp SA, Milone MC.trypsinized, PBS-washed tumor line cells were incubated with anti-GD2-PE, clone 14G2a (BioLegend, cat no. 357304), purified anti-GD3 (Abcam, cat. no AB11779), or respective isotype controls at 1:30 dilution for 15

(10) Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen ReceptorMolecular therapy : the journal of the American Society of Gene TherapyMay 3, 2017Fisher J, Abramowski P, Wisidagamage Don ND, Flutter B, Capsomidis A, Cheung GW, Gustafsson K, Anderson J.

(11) Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cellsOncoimmunologyJanuary 1, 2016Fisher JP, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K, Anderson J.ZombieTM Yellow fixable viability kit (Biolegend 423104), mouse anti-ganglioside GD2-PE (Biolegend 357304, clone 14G2a). Compensation was carried out using single-color controls and eBioScience OneComp eBeads

(12) Type I interferon induced in mice by infection with Trypanosoma equiperdumThe Journal of infectious diseasesMay 1, 1979M Tálas, E T Gláz

Write a Review

(1)

7/15/2020Robust Results with PE-anti-human GD2 Stephen TurnockGood detection antibody for GD2+ cell lines.

PE anti-human Ganglioside GD2 from BioLegend

Description

BioLegend

Citations (12)

Reviews

PE anti-human Ganglioside GD2 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map